Cyr61 participates in the pathogenesis of acute lymphoblastic leukemia by enhancing cellular survival via the AKT/NF-κB signaling pathway-Reference-Cited by-同舟云学术

Cyr61 participates in the pathogenesis of acute lymphoblastic leukemia by enhancing cellular survival via the AKT/NF-κB signaling pathway

Published:2016-10-11 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zhu Xianjin,Song Yanfang,Wu Conglian,Pan Chuxi,Lu Pingxia,Wang Meihua,Zheng Peizheng,Huo Rongfen,Zhang Chenqing,Li Wanting,Lin Yulin,Cao Yingping,Li Ningli

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep34018.pdf

Reference59 articles.

1. Shah, N., Oseth, L. & LeBien, T. W. Development of a model for evaluating the interaction between human pre-B acute lymphoblastic leukemic cells and the bone marrow stromal cell microenvironment. Blood 92, 3817–3828 (1998).

2. Wu, S. et al. Interaction of bone marrow stromal cells with lymphoblasts and effects of predinsolone on cytokine expression. Leuk Res 29, 63–72 (2005).

3. Purizaca, J., Meza, I. & Pelayo, R. Early lymphoid development and microenvironmental cues in B-cell acute lymphoblastic leukemia. Arch Med Res 43, 89–101 (2012).

4. Chiarini, F. et al. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting. Biochim Biophys Acta 1863, 449–463 (2016).

5. Sison, E. A. & Brown, P. The bone marrow microenvironment and leukemia: biology and therapeutic targeting. Expert Rev Hematol 4, 271–283 (2011).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-initiated cysteine-rich protein 61 decreases acute B-lymphoblastic leukemia chemosensitivity;Journal of Cancer Research and Clinical Oncology;2024-03-26

2. Hypoxia-initiated Cysteine-rich protein 61 secretion promotes chemoresistance of acute B lymphoblastic leukemia cells;American Journal of Cancer Research;2024

3. Serum CYR61 as a potential biomarker to improve breast cancer diagnostics;Biomarkers in Medicine;2022-10

4. Novel polysaccharide extracted from Sipunculus nudus inhibits HepG2 tumour growth in vivo by enhancing immune function and inducing tumour cell apoptosis;Journal of Cellular and Molecular Medicine;2021-07-24

5. NR4A1 knockdown confers hepatoprotection against ischaemia‐reperfusion injury by suppressing TGFβ1 via inhibition of CYR61/NF‐κB in mouse hepatocytes;Journal of Cellular and Molecular Medicine;2021-05-03